MFDS
- Status: likely_approved
🇰🇷 Metaproterenol in South Korea
Metaproterenol (orciprenaline) regulatory status in South Korea.
Marketing authorisation
Metaproterenol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in South Korea
Frequently asked questions
Is Metaproterenol approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Metaproterenol in South Korea?
Marketing authorisation holder not available in our data.